Pregnancy loss is a devastating reality for many, with an estimated 25% of pregnancies ending this way. Most of these losses occur during the first trimester, and a significant portion, approximately half, can be attributed to genetic or chromosomal abnormalities. When pregnancy loss becomes recurrent, occurring three or more times, it can be incredibly challenging to identify the underlying cause. However, two groundbreaking studies presented at the Association for Molecular Pathology's 2025 Annual Meeting & Expo in Boston offer a glimmer of hope and some much-needed answers.
These studies utilized a revolutionary technique known as optical genome mapping (OGM), which provides an incredibly detailed view of the genome, allowing researchers to detect abnormalities that traditional genetic sequencing methods often miss. OGM has the potential to uncover hidden causes of pregnancy loss, providing a new lens through which to understand and address this complex issue.
Unveiling the Hidden Causes
Researchers at Dartmouth–Hitchcock Medical Center delved into the potential of OGM by investigating its ability to detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss. They compared OGM results with those from traditional genetic tests like karyotyping and chromosomal microarray analysis. On average, the researchers identified around 40 structural changes in the genome, focusing on 238 genes known to be linked to recurrent pregnancy loss (RPL).
In two cases, the structural changes directly impacted four crucial RPL-related genes, which also play a role in infertility. Another case revealed a hidden chromosome rearrangement that disrupted genes unrelated to RPL. These findings highlight OGM's ability to uncover genetic changes that standard tests often overlook.
The authors emphasize that OGM, when used alongside traditional genetic tests, can significantly enhance the diagnostic evaluation of recurrent pregnancy loss. This approach provides clinicians with a deeper understanding of the potential genetic causes, offering a more comprehensive picture of this complex issue.
Exploring the Role of Fragile Sites
Some regions of human chromosomes, known as fragile sites, are more susceptible to breaks, gaps, or constrictions, particularly when DNA is under stress during replication or repair. While fragile sites are known to contribute to genomic instability, their connection to recurrent pregnancy loss has not been extensively studied. Researchers at Queens University's Kingston Health Sciences Center and the University of Ottawa set out to investigate this connection.
They studied a 33-year-old patient who had experienced three consecutive early pregnancy losses. Traditional chromosome testing revealed breaks at the rare fragile site FRA16B in approximately one-third of her cells. Using OGM, the researchers discovered that the repeated DNA segment at FRA16B was unusually large, confirming instability that could be linked to pregnancy loss.
This study suggests that fragile sites like FRA16B may be overlooked contributors to reproductive issues. By incorporating OGM into traditional cytogenetic testing, we can gain a clearer and more precise understanding of these fragile sites, potentially identifying previously missed causes of pregnancy loss.
These groundbreaking studies offer a new perspective on the complex issue of recurrent pregnancy loss, highlighting the potential of optical genome mapping to uncover hidden causes and provide more accurate diagnoses. As we continue to explore the intricacies of the human genome, we move closer to understanding and addressing this challenging issue.
